Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $4.58B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 1.66B 1.55B Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MacroGenics USD 192M 90M Mar/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pfizer USD 153.96B 12.4B Mar/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Veracyte USD 3.33B 627M Dec/2025